ACP5 and neoplasm: Furthermore, we found that IKK2-I VI treatment significantly decreased the incidence of bone metastasis, reduced the size and number of osteolytic bone lesions and lessened the number of TRAP+-osteoclasts along the bone-tumor interface (Fig. 3i and Fig. S4c, d).